) reveals a network of interacting transcriptional regulators. Arrows indicate genes that were identified in a genome-wide siRNA screen for factors involved in promoting escape from pluripotency (Yang et al., 2012) . (C) Heat map of normalised Otx2 and Oct4 tag densities at the indicated times following release from pluripotency (-2i), plotted onto 4 kb regions centred on the Otx2 peak summits that time point (indicated in red). The numbers of regions bound by Otx2 at each time point are given in brackets. Data are partitioned based on whether there is co-occurrence of Otx2 and Oct4 binding (Otx2+/Oct4+; top) or Otx2 binding alone (Otx2+/Oct4-; bottom). The second most significant de novo motif discovered in the Otx2 binding regions at each of the time points are shown above the heat maps and in each case resembles the Oct4 consensus site. (D) Heat maps of normalised Otx2 and Oct4 tag densities at the indicated times following release from pluripotency (-2i) and is plotted for 1 kb either side on the union set of all Otx2 peak summits across all timepoints. The total number of regions bound by Otx2 is given in brackets. Data are partitioned based on whether there is co-occurrence of Otx2 and Oct4 binding (Otx2+/Oct4+) or Otx2 binding alone (Otx2+/Oct4-). The two most significant de novo motifs discovered in the Otx2+/Oct4+ (top) or Otx2+/Oct4-(bottom) binding regions at each of the time points are shown to the right. RT-qPCR analysis of mRNA expression of Otx2 levels in (Rex1GFPd2) mESCs and a clonally derived cell line containing a doxycyclin-inducible Otx2 transgene, Otx2/dox-2, from "2i" for 12 hrs. Data are normalised by the geometric mean of two reference genes (Ppia and Gapdh) and are presented as means ± SEM and are the average of three biological replicates (n=3). (K) Quantification of Western blot (see Fig. 2G ) of Oct4 levels upon release of WT (Rex1GFPd2) mESCs and a clonally derived cell line containing a doxycyclin-inducible Otx2 transgene, Otx2/dox-2, from "2i" for 12 hrs. Oct4 depletion (oct4i), the presence (+) or absence (-) of doxycycline (dox) and the proteasome inhibitors, lactacystin and MG132, are indicated. Data are normalised for Erk2 levels and presented as means ± SEM (n=2). Otx2 or Oct4 depletion 12 hr after 2i release from RNAseq experiments. Otx2 binding regions were linked to nearby genes and the top graph summarises the proportions of Otx2 targets which are activated, repressed on unchanged Otx2 (as determined by the effect of Otx2 depletion; >1.5 fold change). The expression of genes these different subgroups were compared with their expression changes following release from 2i for 12 hrs (middle graph). Genes within these subgroups were then further partitioned according to their activation or repression by Oct4 (determined by expression changes following Oct4 depletion; >1.5 fold change). (D-G) of RT-qPCR analysis using the Fluidigm system of mRNA expression of the indicated genes over a 24 hour time course following 2i withdrawal. Cells were treated with control, Otx2 or Oct4 siRNAs where indicated. Data are presented as means ± SD (n=3). RT-qPCR analysis of Otx2 mRNA (A), negative control (C) or selected examples (D) using the Fluidigm system of mRNA expression of the indicated genes in WT (Rex1GFPd2), mESCs and two clonally derived cell lines, Otx2/dox-1 and Otx2/dox-2, containing a doxycyclin-inducible Otx2 transgene. Cells were maintained in 2i media and either left untreated or treated with increasing concentrations (10 and 100 ng/ml) of doxycycline (dox) for 24 hrs. Data are presented as means ± SEM and are the average of at least three biological replicates (n ≥ 3). Gene expression following release from 2i for 12 hrs is also shown. (B) Immunoblots showing Otx2 and Oct4 levels in WT (Rex1GFPd2), mESCs and two clonally derived cell lines, Otx2/dox-1 and Otx2/dox-2, containing a doxycyclin-inducible Otx2 transgene. Cells were maintained in 2i media and either left untreated or treated with increasing concentrations (10 and 100 ng/ml) of doxycycline (dox) for 24 hrs. Quantification of the data from (B) is shown below and are normalised for Erk2 levels and presented as means ± SEM (n=3).
